Compare McKesson Corporation (MCK) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Snowflake Inc — how do they compare? McKesson Corporation trades at $934.65 (market cap $108.46B), while Snowflake Inc trades at $348.79 (market cap $121.15B). The key difference: McKesson Corporation and Snowflake Inc are close in size by market cap, and McKesson Corporation pays a 0.4% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Snowflake Inc for 54 Days on average.
| MCK | SNOW | |
|---|---|---|
Market Cap | $108.46B | $121.15B |
Volume | 712,607 | 3,986,549 |
Sector | Health | Technology |
52-Week High | $995.69 | $356.47 |
52-Week Low | $725.17 | $121.11 |
Typical Hold Time | 74 Days | 54 Days |
Enterprise Value | $115.00B | $121.57B |
Dividend Yield | 0.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $910.33, down 1.23% over 24 hours, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue grew to $359.05 billion in 2025, though net margins remain thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing growth visibility in pharmaceutical distribution.
The outlook remains positive given analyst consensus favoring Buy ratings (80.65%) and a price target of $956.43, implying ~5% upside. Risks include margin pressure from drug pricing dynamics and policy uncertainty, while institutional accumulation and solid cash flow generation support stability. Earnings momentum and strategic partnerships position MCK for sustained growth, though investors should monitor competitive and regulatory headwinds.
Snowflake (SNOW) trades at $332.85, down 0.92% on the day, with technical indicators showing a neutral bias amid strong analyst support. The company demonstrates robust revenue growth, reaching $3.63 billion in 2025, but continues to post significant net losses (-$1.29 billion). Recent developments include a $3.75 billion convertible note offering and expanded partnerships, positioning the company for future growth in the AI data cloud market.
Snowflake presents a compelling growth story with strong revenue momentum and dominant market positioning, though profitability remains a key challenge. The stock offers 25% upside to the consensus price target of $418.03, supported by overwhelming analyst bullishness (81% buy ratings). However, investors face risks from ongoing losses, high valuation multiples, and competitive pressures in the cloud data sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
